
	Where results make sense

Topic: SmithKline Beecham

Related Topics

GlaxoSmithKline

Media imperialism

List of castles

	Our management - Board of Directors - About GSK - GlaxoSmithKline
		He joined SmithKline Beecham in 1990 as President of its pharmaceutical business in North America and served as Chairman, Pharmaceuticals from 1994 until his appointment as Chief Operating Officer in 1995.
		Sir Ian Prosser was a Non-Executive Director of SmithKline Beecham plc from 1st August 1999 until the completion of the merger with Glaxo Wellcome plc in December 2000.
		Sir Ian was a Non-Executive Director of SmithKline Beecham plc from 1st August 1999 until the completion of the merger with Glaxo Wellcome plc in December 2000.
	gsk.com /about/boardofdirectors.htm (2242 words)

	Smithkline Beecham Lawsuit Attorney \| Lawyer SmithKline Beecham Misled US Doctors Regarding Paxil Use for Children
		SmithKline Beecham Misled US Doctors Regarding Paxil Use for Children
		A class action has been filed against pharmaceutical company SmithKline Beecham Corporation on behalf of all persons who purchased the antidepressant Paxil or Paxil CR (paroxatine) for children under the age of 18 between November 19, 1998, and the present.
		The action alleges that SmithKline conducted three scientific studies to assess the safety and efficacy of Paxil in treating children and adolescents diagnosed with Major Depressive Disorder.
	www.lawcash.com /attorney/3618/smithkline-beecham-lawsuit.asp (1380 words)

	Smithkline Beecham Corp., et al. v. Apotex Corp., et al.
		SmithKline contested the district court’s claim interpretation noting that claim 1 is clear on its face and encompasses PHC hemihydrate in any amount, however small or insignificant.
		SmithKline also sought to assert a claim of induced infringement against Apotex on the theory that anhydrate tablets convert to PHC hemihydrate in the stomach of a patient due to the increased humidity and pressure.
		SmithKline’s assertion that the clinical tests constituted an experimental use of the invention of claim 1 is inconsistent with its claim construction position.
	www.ll.georgetown.edu /federal/judicial/fed/opinions/03opinions/03-1285.html (12472 words)

	Aphton and SmithKline Beecham Form Strategic Alliance. - HighBeam Encyclopedia
		SmithKline Beecham will be responsible for funding all costs of product development, clinical trials and approvals for worldwide marketing and distribution.
		SmithKline Beecham is one of the world's leading Healthcare companies.
		SmithKline Beecham Biologicals is located in Rixensart, Belgium, and is the centre of all SB's activities in the field of vaccine research, development and production.
	www.encyclopedia.com /doc/1G1-50098087.html (1118 words)

	FDA Labeling Requirements Trump Copyright Infringement - SmithKline Beecham Consumer Healthcare, L.P. v. Watson ...
		SmithKline's user's guide and audiotape were developed in the course of its research into producing a method of, and product for, quitting smoking.
		SmithKline's guide and tape are creative works in which it has a substantial investment, and they are integral to both the marketing and use of Nicorette.
		To be sure, as SmithKline noted at oral argument, "same" may be something less than "identical." However, where the language of a document is the "same" as that of a copyrighted work, the former usually infringes the latter.
	biotech.law.lsu.edu /cases/devices/smithkline_v_watson.htm (3891 words)

	GlaxoSmithKline - Merger Information
		The divestitures are being undertaken to secure regulatory approval for SmithKline Beecham's merger with Glaxo Wellcome, which markets the antiemetic Zofran (ondansetron hydrochloride) for chemotherapy, radiotherapy and post-operative associated nausea and vomiting, and the antivirals Zovirax (acyclovir) and Valtrex (valacyclovir).
		The merger, which has been approved by the shareholders of SmithKline Beecham and Glaxo Wellcome, is subject to sanction by the U.K. High Court and antitrust clearance in the United States.
		SmithKline Beecham is currently in a co-promotion agreement with Roche to market Coreg in the U.S., and Roche has exclusive rights to market the product in Canada.
	www.gsk.com /press_archive/mrg_divest.htm (580 words)

	GlaxoSmithKline - Wikipedia, the free encyclopedia
		2000, by merger of Glaxo Wellcome and SmithKline Beecham
		Current members of the board of directors of GlaxoSmithKline are:
		GSK was formed in December 2000 by a merger between Glaxo Wellcome and SmithKline Beecham, both the product of mergers themselves, as recently as 1995 for Glaxo Group Research and Burroughs Wellcome.
	en.wikipedia.org /wiki/GlaxoSmithKline (1184 words)

	SmithKline Beecham Makes Pharmaceutical Solutions Affordable
		SmithKline Beecham's products are household names: Tums antacids, Aquafresh toothpaste, and Nicorette gum are some of the products that have been developed by the multi-billion dollar health care company.
		SmithKline Beecham's future monitoring needs are also satisfied with the revenue-accurate ION® 7700, which can verify utility billing and help establish the best energy contracts when the deregulation of the power industry takes hold.
		SmithKline Beecham is committed to improving the health of people around the world.
	www.pml.com /solutions/case_studies/smithkline_beecham (839 words)

	IBM e-business: jStart Program: Case studies: XML
		Once merger process between SmithKline Beecham and Glaxo Wellcome has been completed (expected by end of August 2000), it is planned to extend this successful proof of concept system into a generic chemical registration framework.
		SmithKline Beecham is a leading healthcare company focused on pharmaceuticals and consumer healthcare while maintaining access to valuable data to support the future of these businesses.
		Glaxo Wellcome and SmithKline Beecham announce on July 5th 2000 that the formal documents relating to their proposed merger to form GlaxoSmithKline, as the company will be known, are being posted today to the shareholders of both companies.
	www-306.ibm.com /software/ebusiness/jstart/casestudies/smithkline.shtml (988 words)

	SmithKline Beecham Makes Pharmaceutical Solutions Affordable
		SmithKline Beecham's products are household names: Tums antacids, Aquafresh toothpaste, and Nicorette gum are some of the products that have been developed by the multi-billion dollar health care company.
		SmithKline Beecham's future monitoring needs are also satisfied with the revenue-accurate ION® 7700, which can verify utility billing and help establish the best energy contracts when the deregulation of the power industry takes hold.
		SmithKline Beecham is committed to improving the health of people around the world.
	www.pwrm.com /solutions/case_studies/smithkline_beecham (839 words)

	BBC News \| BUSINESS \| Profile: SmithKline Beecham
		SmithKline Beecham is one of the world's leading makers of prescription medicines, but has a highly profitable range of non-medical products as well, among them toothpastes and drinks like Ribena, Horlicks and Lucozade.
		Among the drugs that made SmithKline the leading pharmaceutical firm of today are Thorazine, which revolutionised the treatment of mental illness in the 1950s, the development of the first time-release capsule for drugs, and Tagamet, a peptic ulcer therapy which became the world's first drug with annual sales of more than $1bn.
		Jan Leschly, who made SmithKline Beecham the force it is today, was also the man who reportedly scuppered the firm's first attempt to link up with Glaxo Wellcome.
	news.bbc.co.uk /1/hi/business/606830.stm (717 words)

	WHO and SmithKline Beecham Cooperation on Elephantiasis Elimination
		To counter this scourge, the World Health Organization (WHO) and the global healthcare company SmithKline Beecham PLC (SB) have signed a Memorandum of Understanding whereby SB will donate the drug albendazole free of charge to WHO for use by governments and other collaborating organizations working for the global elimination of the disease.
		SmithKline Beecham will continue donating the drug until the disease is eliminated and it will also contribute programme assistance and health education.
		New research has determined that albendazole, which is manufactured by SmithKline Beecham, and which has already become a standard treatment worldwide to combat intestinal parasites, is 99% effective against the parasite that causes lymphatic filariasis when simultaneously administered with other antiparasitic drugs.
	www.who.int /inf-pr-1998/en/pr98-12.html (745 words)

	SmithKline sheds 3 drugs - Aug. 31, 2000
		SmithKline Beecham will sell the rights to its cancer drug Kytril -- used to treat nausea caused by chemotherapy, radiotherapy and operations -- to Roche Holding AG for $1.23 billion and its antiviral products Famvir and Vectavir/Denavir to Novartis AG for $1.63 billion.
		SmithKline Beecham said the action was being taken to secure regulatory approval for its merger with Glaxo Wellcome, which has leading drugs in the same categories.
		SmithKline Beecham said the rights to Coreg allows it grow its presence in the cardiovascular area and enhances its presence is "this important therapeutic category."
	money.cnn.com /2000/08/31/deals/smithkline/index.htm (359 words)

	domain-B : Indian business : companies : SmithKline Beecham to launch anti-diabetic drug
		SmithKline Beecham Pharma India Ltd, the Rs 300-crore subsidiary of the Anglo-US pharma multinational, has applied for an Indian drug registration to introduce its newly developed anti-diabetic drug Avandia.
		Daniel McDonald, managing director, SmithKline Beecham Pharma, says the drug is a therapeutic breakthrough with the potential to generate $2-3 billion in global sales within the next three years.
		SmithKline Beecham Pharma India is investing an additional Rs 1.5 crore in its chemical plant to bring it on par with the global manufacturing standards.
	www.domainb.com /companies/companies_s/skbpharma_india/19990710skbpharma_india.html (339 words)

	SmithKline Beecham in the McSpotlight
		SmithKline Beecham had fourteen subsidiaries in South Africa during the apartheid years, and has operations in Brazil, China, Colombia, El Salvador, Guatemala, Honduras, India, Indonesia, Mexico, and the Philippines.
		SmithKline Beecham features on Greenpeace's ' Filthy 50' list of plants licensed by the National Rivers Authority to discharge toxic waste into the rivers and sea.
		In the year to March 1991, SmithKline Beecham exceeded its discharge consent more than thirty times according to the NRA and/or the RPB.
	www.mcspotlight.org /beyond/companies/beecham.html (258 words)

	SmithKline Beecham and Paxil Petition
		SKB falsely advertises, through its Paxil labeling and otherwise, that only drug abusers are at risk of physical and psychological dependence, and withdrawal problems when tapering back or abruptly discontinuing Paxil usage.
		SKB boasts to the public in advertising that Paxil's "half life" is good for the patient, that a short half life specifically refines brain chemistry and reduces side effects--but they fail to tell the public that Paxil's half life is bad for the patient in terms of addiction and withdrawal problems.
		The SmithKline Beecham and Paxil Petition to Smithkline Beecham was created by Individuals experiencing difficulty with the prescription drug paxil and written by k.
	www.petitiononline.com /oky71/petition.html (250 words)

	GlaxoSmithKline (Site not responding. Last check: )
		Beecham lanza un nuevo antibiótico para combatir una amplia gama de infecciones bacterianas en niños y adultos.
		SmithKline Beecham y Human Genome Science negocian un acuerdo multimillonario de colaboración para identificar y describir las funciones de los genes en el cuerpo humano.
		SmithKline Beecham e Incyte Pharmaceuticals crearon una empresa conjunta — dialDexus — para descubrir y comercializar diagnósticos moleculares novedosos basados en el uso de genomas.
	www.glaxosmithkline.com.ar /subs/nuestrahistoria/mundial/decada70 (880 words)

	SmithKline Beecham PLC to acquire Block Drug Co. for 1.43 times revenue Weekly Corporate Growth Report - Find Articles
		SmithKline Beecham PLC makes such over-the-counter staples as Geritol vitamins, NicoDerm CQ antismoking patches and Aquafresh toothpaste.
		SmithKline Beecham is working with Human Genome Sciences to break ground in genomic medicine.
		SmithKline Beecham sold its clinical laboratory operations to focus on its pharmaceutical business.
	www.findarticles.com /p/articles/mi_qa3755/is_200010/ai_n8905535 (282 words)

	TheStreet.com: Smithkline Beecham Earnings Top Expectations
		Total pharmaceutical sales were $2.32 billion, of which $1.42 billion came from the U.S. However, the company reported it has ordered further Phase III clinical trials on its Ariflo drug for chronic obstructive pulmonary disease, which will delay the eventual launch of the drug by up to a year.
		Smithkline also said it is on track to meet its earnings forecast for 2000.
		Shares of Smithkline were off $2.63 to $65.50, about 4%, in trading just after the open on the New York Stock Exchange.
	www.thestreet.com /stocks/manufacturing/1149845.html (241 words)

	Free Educational Materials Available on SmithKline Beecham Product Web Site
		SmithKline Beecham affirms that no one source can answer all of patients' questions or replace information given by a patient's doctors and nurses.
		SmithKline Beecham Oncology is committed to the research, development, manufacture and marketing of therapeutic and supportive care products in oncology.
		SmithKline Beecham, one of the world's leading healthcare companies, discovers, develops, manufactures and markets pharmaceuticals, vaccines, over- the-counter medicines and health-related consumer products.
	www.prnewswire.com /cgi-bin/stories.pl?ACCT=104&STORY=/www/story/05-11-2000/0001216343&EDATE= (743 words)

	Coley Pharmaceutical Group, Inc.: Coley Pharmaceutical Group and SmithKline Beecham Sign Collaboration (Site not responding. Last check: )
		SmithKline Beecham (NYSE: SBH) (SB) and Coley Pharmaceutical Group (CPG), formerly CpG ImmunoPharmaceuticals, announced today that the companies have entered into a co-exclusive licensing agreement for the development of immunotherapeutic products based on CpG DNA, a broadly enabling technology for immune system stimulation.
		SmithKline Beecham Biologicals is located in Rixensart, Belgium, and is the center of all SB's activities in the field of vaccine research, development and production.
		SmithKline Beecham -- one of the world's leading healthcare companies -- discovers, develops, manufactures and markets pharmaceuticals, vaccines, over-the-counter medicines and health-related consumer products.
	www.coleypharma.com /coley/pr_1001628188.html (751 words)

	[No title]
		SmithKline Beecham has one of the best and fastest growing drugs portfolios amongst the pharmaceutical giants.
		SmithKline's portfolio of drugs puts the company in a prime position in the consolidating pharmaceuticals industry.
		However, we suggest that you speak to your broker in order to discuss whether this security is suitable, given your requirements.
	members.lycos.co.uk /eldo_rado/smithklinebeecham756.htm (368 words)

	Augmentin vs generics
		Unless SmithKline Beecham can justify their anti-generic advertisement it appears to be a serious attack on the work of many organisations such as the World Health Organisation’s Essential Drugs and other Medicines department towards improving access to essential drugs for less wealthy people around the world.
		SmithKline Beecham has not been able to provide any evidence to show that Augmentin has superior efficacy to placebo, let alone alternative antibiotics, for either of those infections.
		At SmithKline Beecham, we are people with purpose, working together to make the lives of people everywhere healthier, striving in everything we do to become The 'Simply Better' Healthcare Company as judged by all those we serve: customers, shareholders, employees and the global community."
	healthyskepticism.org /publications/editions/2000/IN0002.htm (995 words)

	Patent Baristas » Smithkline Beecham Corp., et al. v. Apotex Corp., et al.
		This case has quite a bit of history and in 2003, Seventh Circuit Judge Posner dismissed a patent infringement case involving paroxetine on the ground that the patent was not infringed.
		In 2004, a panel of the Federal Circuit affirmed the judgment, on the alternate ground that the patent was invalid due to public use of the invention more than a year before the patent was applied for because Smithkline conducted clinical trials more than one year prior to filing of the patent application.
		However, Smithkline argued that the clinical trials were an experimental use but the panel ruled that the use was not experimental.
	www.patentbaristas.com /archives/2005/04/11/smithkline-beecham-corp-et-al-v-apotex-corp-et-al (460 words)

	SMITHKLINE BEECHAM PHARMACEUTICALS, Department of Comparative Genetics - C. elegans Genetics
		SmithKline Beecham is a leader in functional genomics as applied to pharmaceutical research and development.
		The Department of Comparative Genetics conducts gene-based biology in model organisms (primarily yeast and mouse) to identify and validate drug targets, to develop drug screens, and to generate animal models for human disease.
		SmithKline Beecham scientists are encouraged to publish their research findings.
	elegans.swmed.edu /Announcements/skb_posn.html (239 words)

Try your search on: Qwika (all wikis)